治疗精神分裂症焦虑症状的Brexpiprazole:对短期和长期试验的综合分析
Zahinoor Ismail1, Shivani Kapadia2, Anton M Palma3
1Departments of Psychiatry, Clinical Neurosciences, and Community Health Sciences; Hotchkiss Brain Institute and O'Brien Institute for Public Health, University of Calgary, Calgary, AB, Canada; and Clinical and Biomedical Sciences, Faculty of Health and Life Sciences, University of Exeter, Exeter, UK.
Current medical research and opinion
|August 27, 2025
概括
布雷克西普拉在减轻成年精神分裂症患者焦虑症状方面表现出有效性. 药物还改善了患者的功能和生活参与, 提供了潜在的新治疗选择.
科学领域:
- 精神病学
- 临床心理学
- 药理学
背景情况:
- 焦虑是精神分裂症患者的一个重要症状,
- 护理人员也认为焦虑是需要有效治疗的首要症状.
- 现有的精神分裂症治疗方法往往无法全面解决焦虑症.
研究的目的:
- 对成年精神分裂症患者的焦虑症状进行疗效,安全性和耐受性的评估.
- 探索焦虑症状减轻,功能改善和患者生活参与之间的关系.
- 分析临床试验数据以后 hoc的方式,以了解brexpiprazole对焦虑的影响.
主要方法:
- 来自三个为期6周的随机双盲试验和两个为期52周的开放扩展试验的综合数据的后期分析.
- 使用阳性和阴性综合征量表 (PANSS) 的G2项测量焦虑.
- 分别使用个人和社会表现量和PANSS子集来评估患者的功能和生活参与度.
主要成果:
- 与安慰剂相比,布雷克西普拉对焦虑症状的显著减少 (p=0. 005).
- 在两种不同的反应定义中,在布雷克斯皮普拉组中观察到更高的焦虑反应率.
- 功能和生活参与度的改善独立于焦虑症状的变化.
结论:
- 布雷克西普拉可以作为治疗成年精神分裂症患者焦虑症状的有效药物.
- 这些发现表明,布雷克斯皮普拉可能对这一群体的整体功能和生活参与产生积极影响.
- 可能需要进一步的研究来证实这些探索性发现和长期影响.
相关概念视频
Anxiolytic Drugs: Benzodiazepines and Buspirone
1.2K
Benzodiazepines are a class of anxiolytic drugs known for their rapid efficacy and high therapeutic-to-lethal dose ratio, but with a potential risk of drug dependence. These drugs are lipophilic, allowing for rapid absorption after oral administration, eventually reaching the central nervous system (CNS). Once in the CNS, benzodiazepines bind to the allosteric site of the GABAA receptor. This binding enhances the inhibitory effects of the neurotransmitter GABA. By doing so, they prevent...
1.2K
Psychosis: Goals of Pharmacotherapy
209
Antipsychotic drugs are a crucial treatment method for acute and chronic psychoses, bipolar illness, and behavioral disorders. The selection of these drugs depends on several factors, including the state of the disease, clinical judgment, possible drug interactions, and the patient's sensitivity to adverse effects. In immediate scenarios, such as delirium and dementia, short-term treatment with low doses of high-potency typical or atypical agents can effectively manage symptom exacerbation.
209
Anxiolytic Drugs: Overview
483
Anxiolytic drugs are vital in managing anxiety disorders by effectively alleviating symptoms such as excessive fear, tachycardia, and tremors. There are several classes of anxiolytic medications, each with unique mechanisms of action and potential side effects.
Primary Types of Anxiolytic Drugs
1. Benzodiazepines:
Benzodiazepines bind to the GABA-A receptor in the brain, enhancing GABA's interaction. This action reduces neurotransmission, effectively blocking anxiety-associated limbic...
Primary Types of Anxiolytic Drugs
1. Benzodiazepines:
Benzodiazepines bind to the GABA-A receptor in the brain, enhancing GABA's interaction. This action reduces neurotransmission, effectively blocking anxiety-associated limbic...
483
Psychosis and Antipsychotic Drugs: Overview
454
The term "psychosis" refers to a spectrum of mental disorders characterized by abnormal thoughts, perceptions, and behaviors. It can manifest as mood disorders, dementia, delirium with psychotic features, substance-induced psychosis with psychotic features, brief psychotic disorder, delusional disorder, schizoaffective disorder, and schizophrenia. Among all these disorders, schizophrenia is the most common psychotic disorder, affecting 1% of the worldwide population. Psychotic...
454
Drug Therapy
97
The advent of drug therapy has profoundly shaped modern mental health care, providing targeted treatments for a range of psychological disorders. Psychotherapeutic drugs, classified into antianxiety, antidepressant, and antipsychotic medications, address symptoms across anxiety disorders, mood disorders, and schizophrenia. While these medications have transformed patient outcomes, they require careful management due to their potential side effects and limitations.
Antianxiety Medications
Antianxiety Medications
97
Nonlinear Pharmacokinetics: Dependence of Elimination Half-Life and Dose Clearance
296
The elimination half-life and drug clearance of drugs following nonlinear kinetics can vary with dosage. The Michaelis-Menten parameters and drug concentration influence these factors. As the dose increases, the elimination half-life tends to lengthen, resulting in a reduction in clearance and a disproportionately larger area under the curve. The total clearance can be derived from the Michaelis-Menten equation for drugs following a one-compartment model.
A study on guinea pigs examined the...
A study on guinea pigs examined the...
296


